Beclometasone E Formoterolo Teva Italia

Beclometasone Dipropionate and Formoterol Fumarate Dihydrate is a combination medication used for managing asthma and chronic obstructive pulmonary disease (COPD). This inhaler helps control symptoms and reduce inflammation in the airways.

Beclometasone Dipropionate and Formoterol Fumarate Dihydrate is primarily used for the maintenance treatment of asthma and COPD. It combines an inhaled corticosteroid (Beclometasone) to reduce inflammation and a long-acting beta-agonist (Formoterol) to relax the muscles in the airways. This dual-action approach helps improve breathing and prevent symptoms like wheezing, shortness of breath, and coughing. The medication is often prescribed for long-term management rather than for immediate relief of acute symptoms.

Common effects of Beclometasone Dipropionate and Formoterol Fumarate Dihydrate may include throat irritation, hoarseness, and a dry mouth. Some users might experience tremors, headaches, or an increased heart rate. These effects are generally mild and temporary, but persistent or severe reactions should be discussed with a healthcare provider.

It is important to use Beclometasone Dipropionate and Formoterol Fumarate Dihydrate as directed by a healthcare professional. Regular use is essential for maintaining control of asthma or COPD symptoms. Patients should rinse their mouth after each use to reduce the risk of throat irritation and fungal infections. This medication should not be used for the treatment of acute asthma attacks or severe COPD exacerbations.

Beclometasone Dipropionate and Formoterol Fumarate Dihydrate may interact with other medications, including beta-blockers, which can reduce the effectiveness of the beta-agonist component. It is also important to avoid using other long-acting beta-agonists simultaneously, as this can increase the risk of side effects. Patients should inform their healthcare provider about all medications they are taking to avoid potential interactions.